Physician profile
Vittal R Nagar
NPI 1245599760
$3,474.15
in general payments reported to CMS, 2019-2025
10 companies · $1,336 in 2025
The $1,336 reported for 2025 was more than what 78% of Pain Medicine (Physical Medicine & Rehabilitation) providers received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $405 · 2021: $164 · 2022: $34.67 · 2023: $151 · 2024: $1,384 · 2025: $1,336.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,633 · Food and Beverage: $1,238.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,633.06 |
| Food and Beverage | $1,237.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,545.15 | 2022-2025 | Wavewriter Alpha Prime 16, Intracept Rf Probe, Fixate |
| Si-Bone, INC. | $1,007.76 | 2025 | |
| Abbott Laboratories | $362.11 | 2019-2025 | Proclaim |
| Medtronic, INC. | $178.70 | 2021-2022 | |
| Nevro Corp. | $139.40 | 2019-2024 | Vyrsa V1 |
| Spr Therapeutics, INC | $134.89 | 2023 | Sprint Pns System |
| Curonix LLC | $41.02 | 2023-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Globus Medical, INC. | $25.36 | 2025 | Vyrsa V1 |
| Stryker Corporation | $22.79 | 2025 | Optablate, Spinejack, Mild Device Kit |
| Abbvie INC. | $16.97 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vittal Nagar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.